A clinical trial to study the effect of individualized homoeopathic medicine and thyroidinum in subclinical hypothyroidism.

Efficacy of individualised homoeopathic medicine versus thyroidinum in the management of subclinical hypothyroidism-a double blind randomised controlled clinical trial. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059810

Enrollment

Registered

2023-11-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism

Interventions

Intervention1: Individualized homoeopathic medicine: Administering Individualized homoeopathic medicine in patients with subclinical hypothyroidism to reduce TSH levels for 6 months. Control Intervent

Eligibility

Inclusion criteria

Inclusion criteria: Patient having TSH value below 10 mlU/L

Exclusion criteria

Exclusion criteria: Malignant thyroid tumors. Immuno-compromised patients. Pregnant women and lactating mother

Design outcomes

Primary

Measure	Time frame
Reducing the TSH level Timepoint: 6 months	—

Secondary

Measure	Time frame
Changes in WHO QOL -BREF scale.Timepoint: 6 months	—

Countries

India

Contacts

Public ContactDR BINURAJ S R

National homoeopathy research institute in mental health

drbinurajsr@gmail.com9446106525

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026